ICU Acquired Neuromyopathy and Diaphragm Function
Diaphragm Function in Patients Acquired Weakness and Neuromyopathy in ICU: Impact on Weaning and Outcome (DIAPH-WEAK ICU)
1 other identifier
observational
60
1 country
1
Brief Summary
Critical illness neuromyopathy is a common disease acquired during ICU stay leading to a deep weakness involving the respiratory muscle work which result in a delayed weaning of mechanical ventilation. The main objective is to quantify the loss of diaphragm function by measuring the diaphragm force (using the non invasive method by phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion) in a selected population of patients with critical illness neuromyopathy (defined as a MRC score \< 48). The second end points are to evaluate its incidence, the consequences on the patients outcome (extubation success or failure; ICU stay) and to evaluate the relations between diaphragm function (twitch airway pressure during airway occlusion, maximal inspiratory pressure and diaphragm thickness evaluated by ultrasound) and peripheral limbs force (evaluated by the Medical Research Council - MRC score).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 19, 2013
CompletedFirst Posted
Study publicly available on registry
October 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedDecember 3, 2014
December 1, 2014
6 months
August 19, 2013
December 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Twitch tracheal pressure during airway occlusion (expressed in cmH2O)
According the standard of care of weaning process; to evaluate the readiness of the patient to be extubated, the setting of the ventilator should be set at 7 cmH20 PRESSURE SUPPORT VENTILATION (PSV) level and zero end expiratory pressure (PEEP=0) during spontaneous mechanical ventilation to mimic the spontaneous breathing trial (SBT).
At the begining of the spontaneous breathing trial
Secondary Outcomes (1)
extubation success (defined as no need reintubation during the 48h after extubation)
Day 28 after ICU admission
Study Arms (1)
Critical illness neuromyopthy
Non invasive phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion
Interventions
Non invasive phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion
Eligibility Criteria
patients acquired weakness and neuromyopathy in ICU
You may qualify if:
- MRC score \<48
- ready for weaning from mechanical ventilation
You may not qualify if:
- previous history of neuromyopathy
- impossibility to perform a magnetic stimulation
- cervical spine injury
- bihemispheric or brain stem lesion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology & Critical Care, St Eloi University
Montpellier, 34000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samir Jaber, MD PhD
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2013
First Posted
October 24, 2013
Study Start
May 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
December 3, 2014
Record last verified: 2014-12